Skip to content

Randomized controlled study comparing iASSIST Knee system versus conventional instrumentation

Randomized controlled study comparing iASSIST Knee system versus conventional instrumentation - iASSIST Comparison Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027545
Enrollment
100
Registered
2017-05-30
Start date
2017-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Joint Diseases

Interventions

Persona TKA with iASSIST Knee as the Investigational group Persona TKA with conventional instrumentation and without iASSIST Knee as the Control group

Sponsors

Zimmer Biomet G. K.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Knee Osteoarthritis (varus deformity only) - Subjects willing to return for follow-up evaluations

Exclusion criteria

Exclusion criteria: - Severe OA deformation (FTA:>190 deg/ <175 deg) - Active Infection (or within 6 weeks after infection) - Sepsis - Osteomyelitis - Any type of implant is inserted in the affected side of lower extremity - Hip and lower limb diseases on the affected side - Uncooperative patient or patient with neurologic disorders who are incapable of following directions - diagnosed Osteoporosis or Osteomalacia - Metabolic disorders which may impair bone formation - Distant foci of infections which may spread to the implant site - Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram - Vascular insufficiency, muscular atrophy or neuromuscular disease

Design outcomes

Primary

MeasureTime frame
The alignment accuracy of the knee femoral and tibial components at 6 months for the investigational group compared to the control group.

Secondary

MeasureTime frame
Health Status after TKA, Operating Room efficiency and Complication rate after TKA for the investigational group compared to the control group.

Countries

Japan

Contacts

Public ContactFumiya Ohmasa

Zimmer Biomet G. K. Clinical Affairs

fumiya.ohmasa@zimmerbiomet.com03-6402-6762

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026